FNY Managed Accounts’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
FNY Managed Accounts's BMY Position: Q1 2018 in Review
FNY Managed Accounts increased its Bristol-Myers Squibb (BMY) stake by 1,074% in Q1 2018, buying an estimated $115K and bringing the position to 1,960 shares worth $123K. The position accounts for 0.15% of the portfolio, ranked #50.
FNY Managed Accounts first reported a position in BMY in Q1 2014 and has held it in 6 quarters since. The position peaked at $208K in Q1 2014. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.
- FNY Managed Accounts held 1,960 shares of Bristol-Myers Squibb worth $123K as of Q1 2018.
- FNY Managed Accounts bought 1,793 Bristol-Myers Squibb shares in Q1 2018, an estimated $115K.
- Bristol-Myers Squibb made up 0.15% of FNY Managed Accounts's portfolio in Q1 2018, its #50 holding.
- FNY Managed Accounts first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 6 quarters since.
- FNY Managed Accounts's Bristol-Myers Squibb position peaked at $208K in Q1 2014.
- 1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.